-
-
Categories
-
-
The Role of Spectral-Domain OCT in the Diagnosis and Management of Neovascular Age-Related Macular Degeneration
SLACK Journals (Aug 13 2011) AMD
-
Spectral-domain optical coherence tomography (SD-OCT) has emerged as the ancillary examination of choice to assist the diagnosis and management of neovascular age-related macular degeneration (AMD). SD-OCT provides more detailed images of intraretinal, subretinal, and subretinal pigment epithelium fluid when compared to time-domain technology, leading to higher and earlier detection rates ... (Read Full Article)
Login to comment
Related Articles
- Measurement of pulsatile total blood flow in the human and rat retina with ultrahigh speed spectral/Fourier domain OCT
- also written by Jay S. Duker
- Optical coherence tomography-based decision making in exudative age-related macular degeneration: comparison of time- vs spectral-domain devices
- also categorized in AMD
- Comparison of retinal thickness measurements and segmentation performance of four different spectral and time domain OCT devices in neovascular age-related macular degeneration
- also categorized in AMD
- Researchers publish super-resolution OCT retina scans to encourage development of AMD-diagnosis software
- also categorized in AMD
- Differences In Macular Morphology Between Polypoidal Choroidal Vasculopathy And Exudative Age-Related Macular Degeneration Detected By Optical Coherence Tomography.
- also categorized in AMD
- Correlation of High-Definition Optical Coherence Tomography and Fluorescein Angiography Imaging in Neovascular Macular Degeneration [Retina]
- also categorized in AMD
- Cirrus HD-OCT: Advanced Imaging Capabilities for Differential Diagnosis in Macular Disease
- also categorized in AMD
- Monitoring Retinal Change in AMD Patients using Cirrus HD-OCT
- also categorized in AMD
- Reproducibility of Choroidal Thickness Measurements Across Three Spectral Domain Optical Coherence Tomography Systems
- also written by Caio V. Regatieri
- Effect of intravitreal bevacizumab (AvastinĀ®) in neovascular age-related macular degeneration using a treatment regimen based on optical coherence tomography: 6- and 12-month results
- also categorized in AMD
-



Recent Comments
Eye on OCT » Contact Us
Zeiss is investigating a range of technologies for the future.
Romar » Contact Us
I would like to know what you think about Swept-Source OCT in glaucoma and if ...
See all recent comments